Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenase

Journal of Lipid Research

Volumn 41, Issue 2, 2000, Pages 163-181

  Capdevila, Jorge H ^a   Falck, John R ^b   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Arachidonic acid epoxygenase; Arachidonic acid monooxygenase; Cytochrome P450; EDHF; EET; Eicosanoids; Fatty acid hydroxylase; HETE; Hyperpolarizing factor; Hypertension; Salt sensitivity

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FATTY ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; ICOSATRIENOIC ACID; ION CHANNEL; OXYGENASE;

ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; CHEMICAL REACTION; ENZYME ACTIVITY; ENZYME SPECIFICITY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ARACHIDONIC ACID; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; EICOSANOIDS; HUMANS; HYPERTENSION; MIXED FUNCTION OXYGENASES; NADP; OXYGENASES; SUBSTRATE SPECIFICITY;

EID: 0033993749     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (216)

1. Smith, W. L. 1992. Prostanoid biosynthesis and mechanism of action. Am. J. Physiol. 263: F181-F191/ and references therein.
2. Smith, W. L., M. R. Garavito, and D. L. DeWitt. 1996. Prostaglandin Endoperoxide H Synthases (Cyclooxygenases) -1 and -2. J. Biol. Chem. 271: 33157-33160 and references therein.
3. Ford-Hutchinson, A. W., M. Gresser, and R. N. Young. 1994. 5-Lipoxygenase. Annu. Rev. Biochem. 63: 383-417 and references therein.
4. DuBois, R. N., S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. A. Van de Putte, and P. E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073 and references therein.
5. McGiff, J. C. 1991. Cytochrome P-450 metabolism of AA. Annu. Rev. Pharmacol. Toxicol. 31: 339-369 and references therein.
6. Oliw, E. H. 1994. Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog. Lipid Res. 33: 329-354 and references therein.
7. Harder, D. R., W. B. Campbell, and R. J. Roman. 1995. Role of cytochrome P450 enzymes and metabolites of AA in the control of vascular tone. J. Vasc. Res. 32: 79-92 and references therein.
8. Makita, K., J. R. Falck, and J. H. Capdevila. 1996. Cytochrome P450, the AA cascade, and hypertension: new vistas for an old enzyme system. FASEB J. 10: 1456-1463 and references therein.
9. McGiff, J. C., M. Steinberg, and J. Quilley 1996. Missing links: Cytochrome P450 arachidonate products. Trends Cardiovasc. Med. 6: 4-10 and references therein.
10. Schwartzman, M. L., J. L. DaSilva, F. Lin, M. Nishimura, and N. G. Abraham. 1996. Cytochrome P450 expression and AA omega-hydroxylation in the kidney of spontaneously hypertensive rat. Nephron. 73: 652-663 and references therein.
11. Rahman, M., J. T. Wright, and J. G. Douglas. 1997. The role of cytochrome P450-dependent metabolites of AA in blood pressure regulation and renal function. Am. J. Hypertension. 10: 356-365 and references therein.
12. Harder, D. R., A. R. Lange, D. Gebremedhin, E. K. Birks, and R. J. Roman. 1997. Cytochrome P450 metabolites of AA as intracellular signaling molecules invascular tissue. J. Vasc. Res. 34: 237-243 and references therein.
13. Ortiz de Montellano, P. R. 1995. Oxygen activation and reactivity. In Cytochrome P450: Structure, Mechanism, and Biochemistry (2nd edition). P. R. Ortiz de Montellano, editor. Plenum Press, New York. 245-304.
14. Waxman, D. J., and T. K. H. Chang. 1995. Hormonal regulation of liver cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry (2nd edition). P. R. Ortiz de Montellano, editor. Plenum Press, New York. 391-418.
15. Nelson, D. R., L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert. 1996. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6: 1-42.
16. Capdevila, J. H., D. Zeldin, K. Makita, A. Karara, and J. R. Falck. 1995. Cytochrome P450 and the metabolism of AA and oxygenated eicosanoids. In Cytochrome P450: Structure, Mechanism, and Biochemistry (2nd edition). P. R. Ortiz de Montellano, editor. Plenum Press, New York. 443-471.
17. Hamberg, M., and B. Samuelsson. 1966. Prostaglandins in human seminal plasma. Prostaglandins and related factors. J. Biol. Chem. 241: 257-263.
18. Kupfer, D., I. Jansson, L. V. Favreau, A. D. Theoharides, and J. B. Schenkman. 1988. Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver: formation of a novel metabolite by a female-specific P-450. Arch. Biochem. Biophys. 262: 186-195.
19. Oliw, E. H. 1989. Biosynthesis of 18(R)-hydroxyeicosatetraenoic acid from arachidonicacid by microsomes of monkey seminal vesicles. J. Biol. Chem. 264: 17845-17853.
20. 1. Eur. J. Biochem. 11: 390-394.
21. Kupfer, D. 1982. Endogenous substrates of monooxygenases: fatty acids and prostaglandins. In Hepatic Cytochrome P-450 Monooxygenase System. J. B. Schenkman and D. Kupfer, editors. Pergamon Press, New York. 157-182.
22. Wong, P. Y. K., K. U. Malik, B. M. Taylor, W. P. Schneider, J. C. McGiff, and F. F. Sun. 1985. Epoxidation of prostacyclin in the rabbit kidney. J. Biol. Chem. 260: 9150-9153.
23. 4 and of their all-trans isomers by human leukocytes and rat liver microsomes. Biochem. Biophys. Res. Commun. 177: 134-139.
24. Marcus, A. J., L. B. Safier, H. L. Ullman, M. J. Brockman, N. Islam, T. D. Oglesby, and R. Gorman. 1984. 12S,20-Dihydroxyeicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S-hydroxyeicosatetraenoic acid produced by thrombin- or collage-stimulated platelets. Proc. Natl. Acad. Sci. USA. 81: 903-907.
25. 4 20-hydroxylase from polymorphonuclear leukocytes. J. Biol. Chem. 259: 3082-3089.
26. Wong, P. Y. K., P. Westlund, M. Hamberg, E. Granstrom, P. W. H. Chao, and B. Samuelsson. 1984. ω-Hydroxylation of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid in humanpolymorphonuclear leukocytes. J. Biol. Chem. 259: 2683-2686.
27. Kikuta, Y., E. Kusunose, K. Endo, S. Yamamoto, K. Sogawa, Y. Fujii-Kuriyama, and M. Kusunose. 1993. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. J. Biol. Chem. 268: 9376-9380.
28. 2 biosynthesis. J. Biol. Chem. 264: 141-150.
29. DiAgustine, R. P., and J. R. Fouts. 1969. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450. Biochem. J. 115: 547-554.
30. Pessayre, D., P. Mazel, V. Descatoire, E. Rogier, G. Feldmann, and J. P. Benhamou. 1979. Inhibition of hepatic drug-metabolizing enzymes by AA. Xenobiotica. 9: 301-310.
31. Cinti, D. L., and M. B. Feinstein. 1976. Platelet cytochrome P-450: A possible role inarachidonate-induced aggregation. Biochem. Biophys. Res. Commun. 73: 171-179.
32. Capdevila, J. H., L. Parkhill, N. Chacos, R. Okita, B. S. Masters, and R. W. Estabrook. 1981. The oxidative metabolism of AA by purified cytochromes P-450. Biochem. Biophys. Res. Commun. 101: 1357-1363.
33. Capdevila, J. H., N. Chacos, J. Werringloer, R. A. Prough, and R. W. Estabrook. 1981. Liver microsomal cytochrome P-450 and the oxidative metabolism of AA. Proc. Natl. Acad. Sci. USA. 78: 5362-5366.
34. Oliw, E. H., and J. A. Oates. 1981. Oxygenation of AA by hepatic microsomes of the rabbit. Mechanism of biosynthesis of two vicinal diols. Biochim. Biophys. Acta. 666: 327-340.
35. Morrison, A. R., and N. Pascoe. 1981. Metabolism of AA through NADPH-dependent oxygenase of renal cortex. Proc. Natl. Acad. Sci. USA. 78: 7375-7378.
36. Capdevila, J. H., N. Chacos, J. R. Falck, S. Manna, A. Negro-Vilar, and S. R. Ojeda. 1983. Novel hypothalamic arachidonate products stimulate somatostatin release from themedian eminence. Endocrinology, 113: 421-423.
37. Jacobson, H. R., S. Corona, J. H. Capdevila, N. Chacos, S. Manna, A. Womack, and J. R. Falck. 1984. Effects of epoxyeicosatrienoic acids on ion transport in the rabbit cortical collecting tubule. In Prostaglandins and Membrane Ion Transport. P. Braquet, J. C. Frolich, S. Nicosia, and R. Garay, editors. Raven Press, New York. 311.
38. Capdevila, J. H., B. Pramanik, J. L. Napoli, S. Manna, and J. R. Falck. 1984. Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver. Arch. Biochem. Biophys. 231: 511-517.
39. Capdevila, J., P. Mosset, P. Yadagiri, Sun Lumin, and J. R. Falck. 1988. NADPH-dependent microsomal metabolism of 14,15-epoxyeicosatrienoic acid to diepoxides and epoxyalcohols. Arch. Biochem. Biophys. 261: 122-132.
40. Zeldin, D. C., J. Kobayashi, J. R. Falck, B. S. Winder, B. D. Hammock, J. R. Snapper, and J. H. Capdevila. 1993. Regio-and enantiofacial selectivity of epoxyeicosatrienoic acidhydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268: 6402-6407.
41. Capdevila, J. H., A. Karara, D. J. Waxman, M. V. Martin, J. R. Falck, and F. P. Guengerich. 1990. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal AA epoxygenase. J. Biol. Chem. 265: 10865-10871.
42. Capdevila, J., L. J. Marnett, N. Chacos, R. A. Prough, and R. W. Estabrook. 1982. Cytochrome P-450-dependent oxygenation of AA to hydroxyeicosatetraenoic acids. Proc. Natl. Acad. Sci. USA. 79: 767-770.
43. Oliw, E. H. 1993. bis-Allylic hydroxylation of linoleic acid and AA by human hepatic monooxygenases Biochim. Biophys. Acta. 1166: 258-263.
44. Brash, A. R., W. E. Boeglin, J. H. Capdevila, S. Yeola, and I. A. Blair. 1995. 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent AA metabolism in rat liver microsomes: analysis of their stereochemistry, and the stereochemistry of their acid-catalyzed rearrangement. Arch. Biochim. Biophys. 321: 485-492.
45. Capdevila, J. H., P. Yadagiri, S. Manna, and J. R. Falck. 1986. Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of AA by microsomal cytochrome P-450. Biochem. Biophys. Res. Commun. 141: 1007-1011.
46. Woollard, P. M. 1986. Stereochemical differences between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem. Biophys. Res. Commun. 136: 169-176.
47. +-ATPase in the cornea. Proc. Natl. Acad. Sci. USA. 84: 8125-8129.
48. Boeglin, W. E., R. B. Kim, and A. R. Brash. 1998. A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. USA. 95: 6744-6749.
49. Sun, D., M. McDonnel, X. S. Chen, M. M. Lakkis, S. N. Isaacs, S. H. Elsea, P. I. Patel, and C. D. Funk. 1998. Human 12(R)-lipoxygenase and the mouse ortholog. Molecular cloning, expression, and gene chromosomal assignment. J. Biol. Chem. 273: 33540-33547.
50. Oliw, E. H. 1993. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by bovine corneal epithelium. Acta. Physiol. Scand. 147: 117-121.
51. Murphy, R. C., J. R. Falck, S. Lumin, P. Yadagiri, J. A. Zirrolli, M. Balazy, J. Masferrer, N. G. Abraham, and M. L. Schwartzman. 1988. 12(R)-Hydroxyeicosatrienoic acid: a vasodilator cytochrome P-450-dependent arachidonate metabolite from bovine corneal epithelium. J. Biol. Chem. 263: 17197-17202.
52. Lu, A. Y. H., K. Junk, and M. J. Coon. 1969. Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three components. J. Biol. Chem. 244: 3714-3721.
53. LAω). J. Biol. Chem. 262: 801-810.
54. p-2). J. Biol. Chem. 62: 13366-13371.
55. Sharma, R. K., M. V. Doig, D. F. V. Lewis, and G. Gibson. 1989. Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 38: 3621-3629.
56. Imaoka, S., S. Tanaka, and Y. Funae. 1989. ω and (ω1)-hydroxylation of lauric acid and AA by rat renal cytochrome P-450. Biochem. Int. 18: 731-740.
57. Kimura, S., N. Hanioka, E. Matsunaga, and F. J. Gonzalez. 1989. The rat clofibrate-inducible CYP4A gene subfamily I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization and identification of a conserved 19-bp upstream element. DNA. 8: 503-516.
58. Kimura, S., J. P. Hardwick, C. A. Kozac, and F. J. Gonzalez. 1989. The rat clofibrate induicible CYP4A subfamily II. cDNA sequence of IVA3, mapping of the Cyp4a locus tomouse chromosome 4, and coordinated and tissue specific regulation of the CYP4A genes. DNA. 8: 517-525.
59. Imaoka, S., K. Nagashima, and Y. Funae. 1990. Characterization of three cytochrome P450s purified from renal microsomes of untreated male rats and comparison with human renal cytochrome P450. Arch. Biochem. Biophys. 276: 473-480.
60. Stromsteadt, M., S. Hayashi, P. G. Zaphiropoulos, and J. A. Gustafsson. 1990. Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA Cell Biol. 8: 569-577.
61. Johnson, E. F., D. L. Walker, K. J. Griffin, J. E. Clark, R. T. Okita, S. Muerhoff, and B. S. Masters. 1990. Cloning and expression of three rabbit kidney cDNAs encoding lauric acid ω-hydroxylases. Biochemistry. 29: 873-879.
62. Yokotani, N., R. Bernhardt, K. Sogawa, E. Kusunose, O. Gotoh, M. Kusunose, and Y. Fujii-Kuriyama. 1989. Two forms of ω-hydroxylase toward prostaglandin A and laurate. cDNA cloning and their expression. J. Biol. Chem. 264: 21665-21669.
63. kd which shows a fatty acid ω-hydroxylating activity. Eur. J. Biochem. 196: 531-536.
64. 2,-terminal amino acid sequences of human and rat kidney fatty acid ω-hydroxylases. Biochem. Biophys. Acta. 1123: 156-162.
65. Roman, L. J., C. N. A. Palmer, J. E. Clark, S. A. Muerhoff, K. L. Griffin, E. F. Johnson, and B. S. S. Masters. 1993. Expression of rabbit cytochrome P4504A which catalyzes the ω-hydroxylation of AA, fatty acids, and prostaglandins. Arch. Biochem. Biophys. 307: 57-65.
66. Sawamura, A., E. Kusunose, K. Satouchi, and M. Kusunose. 1993. Catalytic properties of rabbit kidney fatty acid ω-hydroxylase cytochrome P-450ka2 (CYP4A7). Biochim. Biophys. Acta. 1168: 30-36.
67. Palmer, C. N. A., T. H. Richardson, K. J. Griffin, M. Hsu, A. S. Muerhoff, J. E. Clark, and E. F. Johnson. 1993. Characterization of a cDNA encoding a human kidney cytochrome P-450 4A fatty acid ω-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim. Biophys. Acta. 1172: 161-166.
68. Imaoka, S., H. Ogawa, S. Kimura, and F. J. Gonzalez. 1993. Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. DNA Cell Biol. 12: 893-899.
69. Nguyen, X., M-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman. 1999. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform specific inhibitors. Am. J. Physiol. 276: R1691-R1700.
70. Wang, M. H., D. E. Stec, M. Balazy, V. Mastyugin, C. S. Yang, R. J. Roman, and M. L. Schwartzman. 1997. Cloning, sequencing, and cDNA-direcled expression of rat renal CYP4A2: AA ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys. 336: 240-250.
71. Helvig, C., E. Dishman, and J. H. Capdevila. 1998. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. Biochemistry. 37: 12546-12558.
72. Johnson, E. F., C. A. N. Palmer, K. J. Griffin, and H. Mei-Hui. 1996. Role of the peroxisome-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10: 1241-1248 and references therein.
73. Masters, B. S., R. T. Okita, A. S. Muerhoff, M. T. Leithauser, A. Gee, S. Winquist, D. L. Roerig, J. E. Clark, R. C. Murphy, and P. R. Ortiz de Montellano. 1989. Pulmonary p-450-mediated eicosanoid metabolism and regulation in the pregnant rabbit. Adv. Prostaglandin Thromboxane Leukotriene Res. 19: 335-338.
74. Sharma, R. K., B. G,. Lake, R. Makowski, T. Bradshaw, D. Earnshaw, J. W. Dale, and G. G. Gibson. 1989. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Eur. J. Biochem. 184: 69-78.
75. Orellana, M., E. Valdes, J. H. Capdevila, and L. Gil. 1989. Nutritionally triggered alterations in the regiospecificity of AA oxygenation by rat liver microsomal cytochrome P450. Arch. Biochem. Biophys. 274: 251-258.
76. Kroetz, D. L., P. Yook, P. Costet, P. Bianchi, and T. Pineau. 1998. Peroxisome proliferator-activated receptor alpha controls hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 273: 31581-31589.
77. Waxman, D. J. 1999. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369: 11-23.
78. Laethem, R. M., M. Balazy, D. R. Falck, C. L. Laethem, and D. R. Koop. 1993. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome 450 2E1. J. Biol. Chem. 268: 12912-12918.
79. Falck, J. R., S. Lumin, I. Blair, E. Dishman, M. V. Martin, D. J. Waxman, F. P. Guengerich, and J. H. Capdevila. 1990. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J. Biol. Chem. 265: 10244-10249.
80. Rifkind, A. B., A. Kanetoshi, J. Orlinick, J. H. Capdevila, and C. Lee. 1994. Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J. Biol. Chem. 269: 3387-3396.
81. Heng, Y. M., S. Kuo, P. S. Jones, R. Savory, R. M. Schultz, S. R. Tomlinson, T. J. Gray, and D. R. Bell. 1997. A novel murine gene, Cyp4a14, is part of a cluster of Cyp4a and 4b, but not Cyp4F genes in mouse and humans. Biochem. J. 325: 741-749.
82. Sundseth, S. S., and D. J. Waxman. 1992. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem. 267: 3915-3921.
83. Oliw, E. H., F. P. Guengerich, and J. A. Oates. 1982. Oxygenation of AA by hepatic monooxygenases. J. Biol. Chem. 257: 3771-3781.
84. Chacos, N., J. R. Falck, C. Wixtrom, and J. Capdevila. 1982. Novel epoxides formed during the liver cytochrome P-450 oxidation of AA. Biochim. Biophys. Res. Commun. 104: 916-922.
85. Karara, A., E. Dishman, I. Blair, J. R. Falck, and J. H. Capdevila. 1989. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic AA epoxygenase. J. Biol. Chem. 264: 19822-19827.
86. Karara, A., E. Dishman, H. Jacobson, J. R. Falck, and J. H. Capdevila. 1990. Arachidonic acid epoxygenase. Stereochemical analysis of the endogenous epoxyeicosatrienoic acids of human kidney cortex. FEBS Lett. 268: 227-230.
87. Falck, J. R., V. J. Schueler, H. R. Jacobson, A. K. Siddhanta, B. Pramanik, and J. Capdevila. 1987. Arachidonate epoxygenase: Identification of epoxyeicosatrienoic acids (EETs) in rabbit kidney. J. Lipid Res. 28: 840-846.
88. Karara, A., S. Wei, D. Spady, L. Swift, J. H. Capdevila, and J. R. Falck. 1992. AA epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem. Biophys. Res. Commun. 182: 1320-1325.
89. Capdevila, J. H., S. Wei, Y. Yan, A. Karara, H. R. Jacobson, J. R. Falck, F. P. Guengerich, and R. N. DuBois. 1992 Cytochrome P-450 AA epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267: 21720-21726.
90. Weiss, R. H., J. L. Arnold, and R. W. Estabrook. 1987. Transformation of an arachidonicacid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch. Biochim. Biophys. 252: 334-338.
91. Karara, A., K. Makita, H. R. Jacobson, J. R. Falck, F. P. Guengerich, R. N. DuBois, and J. H. Capdevila. 1993. Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 AA epoxygenase. J. Biol. Chem. 268: 13565-13570.
92. Zeldin, D. C., R. N. DuBois, J. R. Falck, and J. H. Capdevila. 1995. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch. Biochem. Biophys. 322: 76-86.
93. Daikh, B. E., R. M. Laethem, and D. Koop. 1994. Stereoselective epoxidation of AA by cytochrome P-450s 2CAA and 2C2. J. Pharmacol. Exp. Ther. 269: 1130-1135.
94. Zeldin, D. C., J. Foley, J. E. Boyle, C. R. Moomaw, K. B. Tomer, C. Parker, C. Steenbergen, and S. Wu. 1997. Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology. 138: 1338-1346.
95. Wu, S., C. R. Moomaw, K. B. Tomer, J. R. Falck, and D. C. Zeldin 1996. Molecular cloning and expression of CYP2J2, a human cytochrome P450 AA epoxygenase highly expressed in heart. J. Biol. Chem. 271: 3460-3468.
96. Keeney, D. S., C. Skinner, S. Wei, T. Friedberg, and M. R. Waterman. 1998. A keratinocyte-specific epoxygenase, CYP2B12, metabolites AA with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 273: 9279-9284.
97. Knickle, L. C., and J. R. Bend. 1994. Bioactivation of AA by the cytochrome P450 monooxygense of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for the formation of epoxyeicosatrienoic acids. Mol. Pharmacol. 45: 1273-1280.
98. Keeney, D. S., C. Skinner, J. B. Travers, J. H. Capdevila, L. B. Nanney, L. E. King, and M. Waterman. 1998. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 273: 32071-32079.
99. Luo, G., D. C. Zeldin, J. A. Blaisdell, E. Hodgson, and J. A. Goldstein. 1998. Cloning, and expression of murine CYP2Cs and their ability to metabolize AA. Arch. Biochem. Biophys. 357: 45-57.
100. Holla, V. R., K. Makita, P. G. Zaphiropoulos, and J. H. Capdevila. 1999. The kidney cytochrome P450 2C23 AA epoxygenase is upregulated during dietary salt loading. J. Clin. Invest. 104: 751-760.
101. Laethem, R. M., J. R. Halpert, and D. R. Koop. 1994. Epoxidation of AA as an active site probe of cytochrome P450 2B isoforms. Biochim. Biophys. Acta. 1206: 42-48.
102. Capdevila, J. H., S. Wei, C. Helvig, J. R. Falck, Y. Belosludtsev, G. Truan, S. Graham-Lorence, and J. A. Peterson. 1996. The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J. Biol. Chem. 271: 22663-22671.
103. Graham-Lorence, S., G. Truan, J. A. Peterson, J. R. Falck, S. Wei, C. Helvig, and J. H. Capdevila. 1997. An active site substitution, F87V, converts cytochrome P450 BM3 into a regio- and stereoselective (14)S, 15(R)-AA epoxygenase. J. Biol. Chem. 272: 1127-1135.
104. Zeldin, D. C., C. R. Moomaw, N. Jesse, K. B. Tomer, J. Beethem, B. D. Hammock, and S. Wu. 1996. Biochemical characterization of the human liver cytochrome P450 AA pathway. Arch. Biochem. Biophys. 330: 87-96.
105. Lund, J., P. G. Zaphiropoulos, A. Mode, M. Warner, and J. A. Gustafsson. 1991. Hormonal regulation of cytochrome P450 gene expression. Adv. Pharmacol. 22: 325-354 and references therein.
106. Karara, A., E. Dishman, J. R. Falck, and J. H. Capdevila. 1991. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem. 266: 7561-7569.
107. Brezinski, M., and C. N. Serhan. 1990. Selective incorporation of 15(S)-hydroxyeiosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc. Natl Acad. Sci. USA. 87: 6248-6252.
108. Legrand, A. B., J. A. Lawson, B. O. Meyrick, I. A. Blair, and J. A. Oates. 1991. Substitution of 15-hydroxyeicosatetraenoic acid in the phosphomositide signaling pathway. J. Biol. Chem. 266: 7570-7577.
109. Bernstrom, K., K. Kayganich, R. C. Murphy, and F. A. Fitzpatrick, 1992. Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J. Biol. Chem. 267: 3686-3690.
110. +2 from rat liver mitochondria. Eur. J. Biochem. 149: 633-639.
111. Sevanian, A., and P. Hochstein. 1985. Mechanisms and consequences of lipid peroxidation in biological systems. Annu. Rev. Nutr: 5: 365-390 and references therein.
112. Gast, K., D. Zirwer, M. Ladhoff, J. Schreiber, R. Koelsch, and K. Kretschmer. 1982. auto-oxidation-induced fusion of lipid vesicle. Biochim. Biophys. Acta. 686: 99-109.
113. Hauser, H., and G. Poupart. 1992. Lipid structure. In The Structure of Biological Membranes. Y. Philip, editor. CRC. Press, Ann Arbor, MI. 3-71 and references therein.
114. Yeagle, P. 1992. The dynamics of membrane lipids. In The Structure of Biological Membranes. Y. Philip, editor. CRC Press, Ann Arbor, MI. 157-174 and references therein.
115. Capdevila, J. H., Y. Jin, A. Karara, and J. R. Falck. 1993. Cytochrome P450 epoxygenase dependent formation of novel endogenous epoxyeicosatrienoyl-phospholipids. In Eicosanoids and Other Bioactive Lipids in Cancer, Inflamation and Radiation Injury S. Nigam, L. J. Marnett, K. V. Honn, and T. L. Walden, Jr., editors. Kluwer Academic Publishers, Boston, MA. 11-15.
116. Chen, J., J. H. Capdevila, D. C. Zeldin, and R. L. Rosenberg. 1999. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol. Pharmacol. 55: 288-295.
117. Henrich, W. L., J. R. Falck, and W. B. Campbell. 1990. Inhibition of renin release by 14, 15-epoxyeicosatrienoic acid in renal cortical slices. Am. J. Physiol. 258: E269-274.
118. Henrich, W. L., J. R. Falck, and W. B. Campbell. 1992. Inhibition of renin secretion from rat renal cortical slices by (R)-12-HETE. Am. J. Physiol. 263: F665-670.
119. Campbell, W. B., and D. R. Harder. 1999. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonir acid in the regulation of tone. Circ. Res. 84: 484-488.
120. Gebremedhin, D., Y. H. Ma, J. D. Imig, D. R. Harder, and R. J. Roman. 1993. Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. J. Vasc. Res. 30: 53-60.
121. 2+ current. J. Physiol. 507: 771-781.
122. Ma, Y. H., D. Gebremedhin, M. I,. Schwartzman, J. R. Falck, J. E. Clark, B. S. Masters, D. R. Harder, and R. J. Roman. 1993. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72: 126-136.
123. Imig, J. D., A. P. Zou, D. E. Stec, D. R. Harder, J. R. Falck, and R. J. Roman. 1996. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270: R217-R227.
124. Lange, A., D. Gebremedhin, J. Narayanan, and D. Harder. 1997. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J. Biol. Chem. 272: 27345-27352.
125. Escalante, B., W. C. Sessa, J. R. Falck, P. Yadagiri, and M. L. Schwartzman. 1989. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther. 248: 229-232.
126. Pratt, P. F., J. R. Falck, K. M. Reddy, J. B. Kurian, and W. B. Campbell. 1998. 20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension. 31: 237-241.
127. Birks, E. K., M. Bousamra, K. Presberg, J. A. Marsh, R. M. Effros, and E. R. Jacobs. 1997. Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue. Am. J. Physiol. 272: L823-L829.
128. Carroll, M. A., M. P. Garcia, J. R. Falck, and J. C. McGiff. 1992. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther. 260: 104-109.
129. Takahashi, K., J. Capdevila, A. Karara, J. R. Falck, H. R. Jacobson, and K. F. Badr. 1990. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am. J. Physiol. 258: F781-F789.
130. Masferrer, J., and K. M. Mullane. 1988. Modulation of vascular tone by 12(R)-, but not 12(S)-hydroxyeicosatetraenoic acid. Eur. J. Pharmacol 151: 487-490.
131. Carroll, M. A., M. Balazy, P. Margiotta, D. D. Huang, J. R. Falck, and J. C. McGiff. 1996. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. 271: R863-R869.
132. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-123.
133. Carroll, M. A., M. P. Garcia, J. R. Falck, and J. C. McGiff. 1990. 5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ. Res. 67: 1082-1088.
134. Tan, J. Z., G. Kaley, and G. H. Gurtner. 1997. Nitric oxide and prostaglandins mediate vasodilation to 5,6-EET in rabbit lung. Adv. Exp. Med. Biol. 407: 561-566.
135. Fulton, D., M. Balazy, J. C. McGiff, and J. Quilley. 1996. Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid. J. Pharmacol. Exp. Ther. 277: 1195-1199.
136. Carroll, M. A., M. Balazy, P. Margiotta, J. R. Falck, and J. C. McGiff. 1993. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J. Biol. Chem. 268: 12260-12266.
137. Imig, J. D., L. G. Navar, R. J. Roman, K. K Reddy, and J. R. Falck. 1996. Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol. 7: 2364-2370.
138. Weintraub, N. L., X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector. 1997. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ. Res. 81: 258-267.
139. Gonzalez, E., A. Jawerbaum, V. Novaro, and M. A. Gimeno. 1997. Influence of epoxyeicosatrienoic acids on uterine function. Prostaglandins Leuko. Essent. Fatty Acids. 56: 57-61.
140. Proctor, K. G., R. Falck, and J. Capdevila. 1987. Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 moonooxygenase. Circ. Res. 60: 50-59.
141. Katoh, T., K. Takahashi, J. Capdevila, A. Karara, J. R. Falck, and K. F. Bard. 1991. Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am. J. Physiol. 261: F578-F586.
142. Carroll, M. A., M. Schwartzman, J. Capdevila, J. R. Falck, and J. C. McGiff. 1987. Vasoactivity of arachidonic acid epoxides. Eur. J. Pharmacol. 138:281-283.
143. Zou, A. P., J. T. Fleming, J. R. Falck, E. R. Jacobs, D. Gebremedhin, D. R. Harder, and R. J. Roman. 1996. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K+ channel activity. Am. J. Physiol. 270: F822-F832.
144. Node, K., Y. Huo, X. Ruan, B. Yangf, M. Spiecker, K. Ley, D. Zeldin, and J. K. Liao. 1999. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 285: 1276-1279.
145. Bauersachs, J., R. Popp, I. Fleming, and R. Busse. 1997. Nitric oxide and endothelium-derived hyperpolarizing factor: formation and interactions. Prostaglandins Leuko. Essent. Fatty Acids. 57: 439-446.
146. Dong, H., G. J. Waldron, D. Galipeau, W. C. Cole, and C. R. Triggle. 1997. NO/PG12-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery. Br. J. Pharmacol. 120: 695-701.
147. Bobadilla, R. A., C. C. Henkel, E. C. Henkel, B. Escalante, and E. Hong. 1997. Possibleinvolvement of endothelium-derived hyperpolarizing factor in vascular responses of abdominal aorta from pregnant rats. Hypertension. 30: 596-602.
148. Adeagbo, A. S. 1997. Endothelium-derived hyperpolarizing factor: characterization as a cytochrome P450 1A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. Am. J. Hypertension. 10: 763-771.
149. Ohlmann, P., M. C. Martinez, F. Schneider, J. C. Stoclet, and R. Andriantsitohaina. 1997. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. Br. J. Pharmacol. 121: 657-664.
150. Fukao, M., Y. Hattori, M. Kanno, I. Sakuma, and A. Kitabatake. 1997. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br. J. Pharmacol. 120: 439-446.
151. Zygmunt, P. M., G. Edwards, A. H. Weston, S. C. Davis, and E. D. Hogestatt. 1996. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol. 118: 1147-1152.
152. Corriu, C., M. Feletou, E. Canet, and P. M. Vanhoutte. 1996. Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery. Br. J. Pharmacol. 117: 607-610.
153. Pfister, S. L., N. Spitzbarth, K. Nithipatikom, W. S. Edgermond, J. R. Falck, and W. B. Campbell. 1998. Identification of the 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J. Chem. 273: 30879-30887.
154. Romero, M. F., Z. T. Madhun, U. Hopfer, and J. G. Douglas. 1991. An epoxygenase metabolite of arachidonic acid 5,6 epoxy-eicosatrienoic acid mediates angiotensin-induced natriuresis in proximal tubular epithelium. Adv. Prostaglandin, Thromboxane, & Leukotrinie Res. 21A: 205-208.
155. Sakairi, Y., H. R. Jacobson, T. D. Noland, J. H. Capdevila, J. R. Falck, and M. D. Breyer. 1995. 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am. J. Physiol. 268: F931-F939.
156. Hirt, D.L., J. Capdevila, J. R. Falck, M. D. Breyer, and H. R. Jacobson. 1989. Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. J. Clin. Invest. 84: 1805-1812.
157. Escalante, B., D. Erlij, J. R. Falck, and J. C. McGiff. 1994. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am. J. Physiol. 266: C1775-1782.
158. Grider, J. S., J. C. Falcone, E. L. Kilpatrick, C. E. Ott, and B. A. Jackson. 1997. P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb. Can. J. Physiol. Pharmacol. 75: 91-96.
159. Zou, A. P., H. A. Drummond, and R. J. Roman. 1996. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension. 27: 631-635.
160. Wang, W., and M. Lu. 1995. Effect of arachidonic and on activity of the apical K+ channel in the thick ascending limb of the rat kidney. J. Gen. Physiol. 106: 727-743.
161. Hu, S., and H. S. Kim. 1993. Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol. 230: 215-221.
162. Li, P. L., and W. B. Campbell 1997. Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ. Res. 80: 877-884.
163. Baron, A., M. Frieden, and J. L. Beny. 1997. Epoxyeicosatrienoic acids activate a high-conductance, Ca(2+)-dependent K+ channel on pig coronary artery endothelial cells. J. Physiol. 504: 537-543.
164. Fisslthaler, B., R. Popp, L. Kiss, M. Potente, D. R. Harder, I. Fleming, and R. Busse. 1999. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 410: 493-497.
165. Escalante, B. A., R. Staudinger, M. Schwartzman, and N. Abraham. 1995. Amiloride-sensitive ion transport inhibition by epoxyeicosatrienoic acids in renal epithelial cells. Adv. Prostaglandin Thromboxane Leukotriene Res. 23: 207-209.
166. Staudinger, R., B. Escalante, M. L. Schwartzman, and N. G. Abraham. 1994. Effects of epoxyeicosatrienoic acids on 86Rb uptake in renal epithelial cells. J. Cell. Physiol. 160: 69-74.
167. + exchange and are mitogenic in cultured rat glomerular mesangial cells. J. Cell. Physiol. 144: 429-437.
168. 1+)-2Cl-cotransport in medullary thick ascending limb: control by PKA, PKC, and 20-HETE. Am. J. Physiol. 271: C455-C463.
169. +-ATPase. J. Clin. Invest. 99: 1224-1230.
170. Ominato, M., T. Satoh, and A. I. Katz. 1996. Regulation of Na-K-ATPase activity in the proximal tubule: role of the protein kinase C pathway and of eicosanoids. J. Membr. Biol. 152: 235-243.
171. Sellmayer, A., W. M. Uedelhoven, P. C. Weber, and J. V. Bonventre. 1991. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J. Biol. Chem. 266: 3800-3807.
172. Harris, R. C., T. J. Homma, and J. Capdevila. 1990. Epoxyeicosatreinoic acids are mitogens for rat mesangial Cells: signal transduction pathways. J. Cell. Physiol. 144: 429-443.
173. Sheu, H. L., K. Omata, Y. Utsumi, E. Tsutsumi, T. Sato, T. Shimizu, and I. C. Abe. 1995. Epoxyeicosatrienoic acids stimulate the growth of vascular smooth muscle cells. Adv. Prostaglandin Thromboxane Leukotriene Res. 23: 211-213.
174. Chen, J. K., J. R. Falck, R. M. Reddy, J. Capdevila, and R. C. Harris. 1998. Epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J. Biol. Chem. 273: 29254-29261.
175. Burns, K. D., J. Capdevila, S. Wei, M. D. Breyer, T. Homma, and R. C. Harris. 1995. Role of cytochrome P-450 epoxygenase metabolites in EGF signaling in renal proximal tubule. Am. J. Physiol. 269: C831-C840.
176. 2+ pool-depleted cells is mediated by specific epoxyeicosatrienoic acids derived from arachidonic acid. J. Biol. Chem. 272: 29546-29553.
177. Lin, F. A. Rios, J. R. Falck, Y. Belosludtsev, and M. L. Schwartzman. 1995. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am. J. Physiol. 269: F806-F816.
178. Uddin, M. R., M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik. 1998. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension. 31: 242-247.
179. Homma, T., J. Y. Zhang, T. Shimizu, C. Prakash, I. A. Blair, and R. C. Harris. 1993. Cyclooxygenase-derived metabolites of 8,9-epoxyeicosatrienoic acid are potent mitogens for cultured rat glomerular mesangial cells. Biochem. Biophys. Res. Commun. 191: 282-288.
180. Peri, K. G., D. R. Varma, and S. Chemtob. 1997. Stimulation of prostaglandin G/H synthase-2 expression by arachidonic acid monoxygenase product, 14,15-epoxyeicosatrienoic acid. FEBS Lett. 416: 269-272.
181. Peri, K. G., G. Almazan, D. R. Varma, and S. Chemtob. 1998. A role for protein kinase C alpha in stimulation of prostaglandin G/H synthase-2 transcription by 14,15-epoxyeicosatrienoic acid. Biochem. Biophys. Res. Commun. 244; 96-101.
182. Hashimoto, T., T. Fujita, N. Usuda, W. Cook, C. Qi, J. M. Peters, F. J. Gonzalez, A. V. Yeldani, S. M. Rao, and J. K. Reddy. 1999. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisomal proliferator activated receptor α and peroxisomal fatty acyl-CoA oxidase. J. Biol. Chem. 274: 19228-19236.
183. Aldridge, T. C., J. D. Tugwood, and S. Green. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306: 473-479.
184. Simpson, A. E., W. J. Brammar, M. K. Pratten, and C. R. Elcombe. 1995. Translactational induction of CYP4A expression in 10.5-day neonatal rats by the hypolipidemic drug clofibrate. Biochem. Pharmacol. 50: 2021-2032.
185. Schlondorff, D., E. Petty, J. A. Oates, M. Jacoby, and S. D. Levine. 1987. Epoxygenase metabolites of arachidonic acid inhibit vasopressin response in toad bladder. Am. J. Physiol. 53: F464-F470.
186. 2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores. Biochem. J. 277: 73-79.
187. 2+ stores. Biochem. J. 280: 783-789.
188. 2+ influx. Biochem. J. 274: 193-197.
189. 2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J. 6: 2742-2747.
190. 2+ entry in human and bovine endothelial cells. J. Physiol. 482: 259-271.
191. Hildebrandt, E., J. P. Albanesi, J. R. Falck, and W. B. Campbell. 1995. Regulation of calcium influx and catecholamine secretion in chromaffin cells by a cytochrome P450 metabolite of arachidonic acid. J. Lipid Res. 36: 2599-2608.
192. Madhun, Z. T., D. A. Goldthwait, D. McKay, U. Hopfer, and J. G. Douglas. 1991. An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells. J. Clin. Invest. 88: 456-461.
193. Rzigalinski, B. A., K. A. Willoughby, S. W. Hoffman, J. R. Falck, and E. F. Ellis. 1999. Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid. J. Biol. Chem. 274: 175-182.
194. Wong, P. Y., K. T. Lin, Y. T. Yan, D. Ahern, J. Iles, S. Y. Shen, R. K. Bhatt, and J. R. Falck. 1993. 14(R), 15(S)-epoxyeicosatrienoic acid (14(R), 15(S)-EET) receptor in guinea pig mononuclear cell membranes. J. Lipid Mediat. 6: 199-208.
195. Stoltz, R. A., and M. L. Schwartzman. 1997. High affinity binding sites for [12(R)-HETrE] in microvessel endothelial cells. J. Ocular Pharmacol. Ther. 13: 191-199.
196. Seki, K., A. Hirai, M. Noda, Y. Tamura, I. Kato, and S. Yoshida. 1992. Epoxyeicosatrienoic acid stimulates ADP-ribosylation of a 52 kDa protein in rat liver cytosol. Biochem. J. 281: 185-190.
197. Wong, P. Y. K., P. S. Lai, S. Y. Shen, Y. Y. Belosludtsev, and J. R. Falck. 1997. Post-receptor signal transduction and regulation of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J. Lipid Mediat. Cell Signal. 16: 155-169.
198. + channel activityand vascular tone in renal arterioles. Cirr. Res. 83: 1069-1079.
199. Omata, K., N. G. Abraham, and M. L. Schwartzman. 1992. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am. J. Physiol. 262: F591-F599.
200. Chen, J. K., D. W. Wang, J. R. Falck, J. Capdevila, and R. C. Harris. 1999. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J. Biol. Chem. 274: 4764-4769.
201. Houillier, P., R. Chamrey, J. M. Achard, M. Froissart, J. Poggioli, and M. Paillard. 1996. Signaling pathways in the biphasic effect of angiostensin II on apical Na/H antiport activity in proximal tubule. Kidney Int. 50: 1496-1505.
202. Ribeiro, C. M., G. R. Dubay, J. R. Falck, and L. J. Mandel. 1994. Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway. Am. J. Physiol. 266: F497-F505.
203. Oyekan, A. O., K. McAward, and J. C. McGiff. 1998. Renal functtional effects of endothelins: dependency on cytochrome P450-derived arachidonate metabolites. Biol. Res. 31: 209-215.
204. Muthalif, M. M., I. F. Benter, N. Karzoun, S. Fatima, J. Harper, M. R. Uddin, and K. U. Malik. 1998. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA. 95: 12701-12706.
205. Harder, D. R., N. J. Alkayed, A. R. Lange, D. Gebremedhin, and R. J. Roman. 1998. Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke. 29: 229-234.
206. + channels in rat TAL. Am. J. Physiol. 273: F421-F429.
207. Iwai, N., and T. Inagani. 1991. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension 17: 161-169.
208. Su, P., K. M. Kaushal, and D. L. Kroetz. 1998. Inhibition of renal AA w-hydroxylase activity with ABT reduced blood pressure in the SHR. Am. J. Physiol. 275: R426-R438.
209. Wang, M. H., H. Guan, X. Nguyen, B. A. Zand, A. Nasjlettii and M. Laniado-Schwartzman. 1999. Contribution of cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am. J. Physiol. 276: F246-F253.
210. Rapp, J. P. 1982. Dahl salt-susceptible and Dahl salt-resistant rats. A review. Hypertension. 4: 753-763.
211. Stec, D. E., D. L. Mattson, and R. J. Roman. 1997. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. Hypertension. 29: 315-319.
212. Ma, Y. H., M. L. Schwartzman, and R. J. Roman. 1994. Altered renal P-450 metabolism of AA in Dahl salt-sensitive rats. Am. J. Physiol. 267: R579-R589.
213. Zhou, A. P., H. A. Drummond, and R. J. Roman. 1996. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr. rats. Hypertension. 27: 631-635.
214. Stec, D. E., A. Y. Deng, J. P. Rapp, and R. J. Roman. 1996. Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats. Hypertension. 27: 564-568.
215. Makita, K., K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck, and J. H. Capdevila. 1994. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest. 94: 2414-2420.
216. Oyekan, A. O., T. Youseff, D. Fulton, J. Quilley, and J. C. McGiff. 1999. Renal cytochrome P450 ω-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J. Clin. Invest. 104: 1131-1137.